- Home
- SYNX vs ADVB Comparison
SYNX vs ADVB Comparison
Compare SYNX & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- ADVB
- Stock Information
- Founded
- SYNX 2005
- ADVB 2014
- Country
- SYNX Israel
- ADVB United States
- Employees
- SYNX N/A
- ADVB N/A
- Industry
- SYNX
- ADVB Medical Specialities
- Sector
- SYNX
- ADVB Health Care
- Exchange
- SYNX Nasdaq
- ADVB Nasdaq
- Market Cap
- SYNX 10.2M
- ADVB 9.7M
- IPO Year
- SYNX 2024
- ADVB 2025
- Fundamental
- Price
- SYNX $1.08
- ADVB $0.42
- Analyst Decision
- SYNX
- ADVB
- Analyst Count
- SYNX 0
- ADVB 0
- Target Price
- SYNX N/A
- ADVB N/A
- AVG Volume (30 Days)
- SYNX 35.7K
- ADVB 1.7M
- Earning Date
- SYNX 09-26-2025
- ADVB 11-19-2025
- Dividend Yield
- SYNX N/A
- ADVB N/A
- EPS Growth
- SYNX N/A
- ADVB N/A
- EPS
- SYNX N/A
- ADVB N/A
- Revenue
- SYNX $6,003,000.00
- ADVB N/A
- Revenue This Year
- SYNX $32.35
- ADVB N/A
- Revenue Next Year
- SYNX N/A
- ADVB N/A
- P/E Ratio
- SYNX N/A
- ADVB N/A
- Revenue Growth
- SYNX N/A
- ADVB N/A
- 52 Week Low
- SYNX $1.00
- ADVB $0.34
- 52 Week High
- SYNX $6.49
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- SYNX 21.05
- ADVB 47.63
- Support Level
- SYNX $1.20
- ADVB $0.36
- Resistance Level
- SYNX $1.28
- ADVB $0.49
- Average True Range (ATR)
- SYNX 0.09
- ADVB 0.04
- MACD
- SYNX -0.04
- ADVB -0.00
- Stochastic Oscillator
- SYNX 3.70
- ADVB 44.36
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.